$2.15
-0.15-6.33%
最終更新: Nov 13, 12:09 PM
Benzinga
Benzinga
Benzinga
金曜日, 11 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Abeona Therapeutics fell 49.4% from $4.53 to $2.29, behind the S&P 500's +12.7%. Its worst day was Nov 9 (−39.1%), and its low came Nov 12 at $2.29.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.34 beat the $-0.36 estimate on $5.4M revenue (est. $4.9M).
−3.8% · S&P 500 +0.3%
EPS of $-0.30 beat the $-0.38 estimate on $8.7M revenue (est. $5.1M).
Story events cover the past 12 months · Times ET
+0.5% · S&P 500 +0.6%
EPS of $-0.35 missed the $-0.24 estimate on $11.4M revenue (est. $12.3M).
−14.9% · S&P 500 +0.7%
EPS of $-0.08 beat the $-0.16 estimate on $13.5M revenue (est. $15.5M).
−39.1%, the year's worst day, on 14M shares, the year's heaviest volume · S&P 500 +2.4%
Where it ended: a close of $2.29 on Nov 12, 2026.
Nothing in the past 12 months.
All ABEO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ABEO and SPY from Benzinga historical bars. Not investment advice.